01 January 2000
Stimulation by nitric oxide of HCO3- secretion in bullfrog duodenum in vitro - role of cyclooxygenase-1 and prostaglandins
Osamu Furukawa, Shoji Kawauchi, Hiroshi Mimaki, Koji TakeuchiMed Sci Monit 2000; 6(3): BR454-459 :: ID: 421326
Abstract
The effect of nitric oxide (NO) on HCO3- secretion was examined in vitrousing the isolated preparation of bullfrog duodenum, in relation to cyclooxygenase (COX) isozymes andendogenous prostaglandins (PGs). The tissue was bathed in unbuffered Ringer solution gassed with 100%O2 on the mucosal side and HCO3- Ringer's solution gassed with 95% O2-5% CO2 on the serosal side. TheHCO3- secretion was measured by a pH-stat method using 10 mM HCl as the titrant to keep the mucosal pHat 7.4. NOR-3 [(+/-)-(E)-Ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamine] was used as a NO donor andadded to the serosal solution. To analyze the NOR-3 action, the effects of dibutyryl guanosine-3', 5'-cyclicmonophosphate (dbcGMP), methylene blue, indomethacin (nonselective COX-inhibitor) and NS-398 (selectiveCOX-2 inhibitor) on the HCO3- response were also examined. NOR-3 (1 x 10(-4) and 3 x 10(-4) M) causedan increase of HCO3- secretion in a dose-dependent manner, reaching the level of 2.5 times greater thanbasal values at 2 hr later. Likewise, dbcGMP (1 x 10(-3) M) also caused a significant increase of theduodenal HCO3- secretion. The HCO3- stimulatory action of NOR-3 was significantly attenuated by methyleneblue (5 x 10(-5) M) and indomethacin (1 x 10(-5) M) but not by NS-398 (1 x 10(-5) M), and indomethacinalso suppressed the HCO3- response to dbcGMP. The serosal release of PGE2 was significantly increasedby both NOR-3 and dbcGMP, and these responses were inhibited by indomethacin but not NS-398. These resultssuggest that NO increases HCO3- secretion in Bullfrog duodenum in vitro, and this action is dependenton cGMP-related COX-1 activation and mediated by PGs.
Keywords: 16,16-Dimethylprostaglandin E2, Bicarbonates, Cyclooxygenase Inhibitors, Dibutyryl Cyclic GMP, Dinoprostone, Duodenum, Indomethacin, Intestinal Mucosa, Isoenzymes, Kinetics, Methylene Blue, Nitric Oxide Donors, Nitro Compounds, Nitrobenzenes, Prostaglandin-Endoperoxide Synthase, Prostaglandins, Rana catesbeiana, Sulfonamides
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952